Autoclaves are among the unsung heroes of everyday laboratory work. They run in the background, sterilize media, decontaminate waste, and ensure the safety of processes—often for years on end without attracting much attention. But that is precisely the problem: as long as an autoclave “still works,” the question of replacing it tends to be put off.
However, in the life sciences sector, this logic has changed fundamentally in recent years. Today, the question is no longer simply whether a device is still technically operational. Rather, the decisive factor is whether it still meets current requirements for process safety, validatability, and integration.
From a Rugged Device to a Mission-Critical System
In the past, an autoclave was primarily a mechanical-thermal system. As long as the pressure, temperature, and time were correct, the process was considered safe. Today, this view is no longer sufficient. In modern laboratories, the autoclave has long been part of a larger system, particularly in the pharmaceutical, biotech, and regulated research sectors. Sterilization processes must not only work, but must do so in a verifiable and reproducible manner throughout their entire lifecycle.
Sterilization processes must not only work, but also be verifiably effective. This is precisely where the difficulties with older equipment begin. As equipment ages, not only does the risk of technical failures increase, but—more importantly—so does the effort required to actually provide the necessary documentation. Sensors drift, repeatability decreases, and documentation becomes incomplete or can only be done manually. What initially seems like a minor additional burden in day-to-day operations quickly becomes a systemic problem during an audit.
Today, one of the key references for these requirements is the ISO 17665:2024 standard. It clearly states that sterilization processes must be monitored, validated, and documented throughout their entire lifecycle. An autoclave is therefore no longer just a piece of equipment—it is a process system that must be validated.
Regulatory requirements are becoming stricter—even in the lab
Even though many life science laboratories do not operate directly as “medical facilities,” they are nonetheless increasingly subject to regulatory requirements. At the very least in GMP- or GLP-related environments, processes must be reproducible, traceable, and audit-ready.
In addition to ISO 17665, standards such as EN 285 (for containers with a capacity of 60 liters or more, or a minimum STU* capacity) and the updated EN 13060:2025 play an important role here, defining performance requirements and test procedures. It is particularly relevant that these standards are continuously being updated and harmonized with the MDR framework—most recently, for example, through EU Decision 2026/760, which officially adopts new versions.
For laboratory operations, this represents a subtle but clear shift: An autoclave must not only function properly, but also be able to demonstrate at all times that it operates in accordance with the current state of the art.
*STU: A sterilization unit is defined by standard and corresponds to a volume of 300 × 300 × 600 mm (W×H×D)
The Silent Tipping Point: When Validation Becomes a Challenge
In practice, it is rarely a single defect that triggers a replacement. Much more often, it is a gradual process. Validation becomes more time-consuming, calibrations must be performed more frequently, and individual cycles become less stable. At the same time, the documentation burden increases due to the lack of automated systems.
At some point, a situation arises in which operations are still possible, but only with increasing effort and growing uncertainty. That is precisely the actual tipping point.
An autoclave that can no longer be validated efficiently will sooner or later become a risk. Not necessarily because it will fail immediately, but because it can no longer reliably demonstrate process integrity. In an environment where audits, traceability, and data integrity are critical, this is a decisive factor.
Digitalization is fundamentally changing the requirements
Another aspect that is often underestimated is the increasing digitization of laboratory operations. Today’s modern life science environments rely on networked systems, centralized data collection, and ever-increasing requirements for documentation and transparency.
An autoclave is no longer a standalone device; rather, it must integrate into an infrastructure comprising LIMS, quality management systems, and digital workflows. Batch data should be stored automatically, processes must be traceable, and, ideally, devices can be monitored centrally.
It is precisely at this point that many older autoclaves reveal that they no longer fit today’s workflows. A lack of interfaces or cloud connectivity, outdated software, or the absence of data storage mean that processes must be documented manually—with all the associated risks.
Added to this is an issue that will continue to gain importance in the coming years: data integrity and IT security. Systems that cannot be updated or that use proprietary control systems that are no longer supported pose a growing risk in this regard. In practice, therefore, we are seeing this more and more often: the replacement of an autoclave is no longer driven by wear and tear, but by a lack of integration capabilities.
Cost-effectiveness makes a difference—even if its benefits often become apparent only later
The cost structure evolves in parallel. While an autoclave operates very reliably in its first few years, costs begin to rise after about 8 to 10 years. Maintenance becomes more frequent, replacement parts become more expensive, and breakdowns occur less regularly but have a greater impact.
The most critical factor here is not the direct service costs, but rather the indirect effects. Interrupted test series, delayed production steps, or additional validation efforts incur costs that are often not immediately apparent—but can be decisive when viewed in the bigger picture. In many laboratories, a simple reality serves as a rough guideline: When ongoing expenses approach a significant proportion of the cost of a new piece of equipment, the economic threshold has been reached. At that point, at the latest, it’s worth taking a strategic look ahead.
Conclusion: The key question is not age
In the life sciences sector today, replacing an autoclave is less a matter of years than a matter of future-readiness. A device can be 12 years old and continue to operate without any problems—provided it is technically stable, validatable, and integrable. Another system may reach this point much sooner because its design no longer meets the laboratory’s requirements.
The key question, therefore, is: Can your autoclave still reliably handle today’s and tomorrow’s processes, or is your lab already working around the machine? If the latter is the case, the next step is usually clear. Not as a reaction to a malfunction, but as a conscious decision to ensure stability, efficiency, and safety in lab operations.
do you have any questions about this article?
We will be happy to help you.
